Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback